ABBOTT INTRODUCES ACARIZAX TO CONTROL RESPIRATORY ALLERGY

Acarizax is now available in Malaysia - a clinically proven under the tongue (sublingual) immunotherapy tablet that treats the underlying cause of house dust mite respiratory allergy, as opposed to just relieving symptoms.
A prescriptive drug, Acarizax is a novel treatment indicated for persistent moderate-to-severe house dust mite allergic rhinitis in adult (18 - 65 years) and adolescent (12 - 17 years) patients and house dust mite allergic asthma in adults.
Read more: healthcaretoday...